TFA
CDAK

Toth Financial Advisory’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Toth Financial Advisory’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100
Closed -$1K – 831
2021
Q4 		$1K Hold
100
– – ﹤0.01% 732
2021
Q3 		$2K Hold
100
– – ﹤0.01% 685
2021
Q2 		$2K Buy
+100
New +$1.92K ﹤0.01% 629

Other funds holding CDAK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Toth Financial Advisory's CDAK Position: Q1 2022 in Review

Toth Financial Advisory sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q1 2022, closing a stake of 100 shares — an estimated $1K sold.

Toth Financial Advisory first reported a position in CDAK in Q2 2021 and held it in 3 quarters. The position peaked at $2K in Q3 2021. 62 funds tracked by Wall St. Rank hold CDAK as of Q1 2022.

  • Toth Financial Advisory reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Toth Financial Advisory sold 100 Codiak BioSciences, Inc. Common Stock shares in Q1 2022, an estimated $1K.
  • Toth Financial Advisory first reported a position in Codiak BioSciences, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Toth Financial Advisory's Codiak BioSciences, Inc. Common Stock position peaked at $2K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q1 2022.

Based on Toth Financial Advisory's 13F filing for Q1 2022, filed 26 Apr 2022.